BIIB
Biogen Inc.
Latest News for BIIB
In a report released today, Evan Seigerman from BMO Capital maintained a Hold rating on Biogen, with a price target of $150.00. The company’s share......
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Biogen, with a price target of $210.00. The company’s sh......
Needham analyst Ami Fadia maintained a Hold rating on Biogen today. The company’s shares closed yesterday at $147.86. Fadia covers the Healthcare s......
Biogen Inc. (($BIIB)) announced an update on their ongoing clinical study. Biogen Inc. is conducting a study titled Pregnancy Outcomes in Women Exp......
Biogen Inc. (($BIIB)) announced an update on their ongoing clinical study. Biogen Inc. is conducting a Phase 3 clinical study titled A Phase 3, 2-P......
Bernstein analyst William Pickering maintained a Hold rating on Biogen today and set a price target of $155.00. The company’s shares closed last Fr......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $175.30 | +4.2% | 2.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |